4.7 Article

Dual SMAD Signaling Inhibition Enables Long-Term Expansion of Diverse Epithelial Basal Cells

Journal

CELL STEM CELL
Volume 19, Issue 2, Pages 217-231

Publisher

CELL PRESS
DOI: 10.1016/j.stem.2016.05.012

Keywords

-

Funding

  1. NIH [R01HL116756, R01HL118185, DK047967, HL051670, K08HL124298, T32HL087735, K99HL127181, R00 AR063127]
  2. Cystic Fibrosis Foundation [RAJAGO12G0, RAJAGO12I0]
  3. Smith Family Awards
  4. March of Dimes Basil O'Connor Starter Scholar Awards

Ask authors/readers for more resources

Functional modeling of many adult epithelia is limited by the difficulty in maintaining relevant stem cell populations in culture. Here, we show that dual inhibition of SMAD signaling pathways enables robust expansion of primary epithelial basal cell populations. We find that TGF beta/BMP/SMAD pathway signaling is strongly activated in luminal and suprabasal cells of several epithelia, but suppressed in p63+ basal cells. In airway epithelium, SMAD signaling promotes differentiation, and its inhibition leads to stem cell hyperplasia. Using dual SMAD signaling inhibition in a feeder-free culture system, we have been able to expand airway basal stemcells from multiple species. Expanded cells can produce functional airway epithelium physiologically responsive to clinically relevant drugs, such as CFTR modulators. This approach is effective for the clonal expansion of single human cells and for basal cell populations from epithelial tissues from all three germ layers and therefore may be broadly applicable for modeling of epithelia.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available